Health ❯ Healthcare ❯ Medical Research

Drug Development

Obesity Treatments Rare Diseases AbbVie Clinical Studies AI in Drug Discovery Insmed Pharmaceuticals Lecanemab AI in Medicine Monoclonal Antibodies Pharmaceutical Testing Alzheimer's Treatments Antibiotic Resistance New Formulations Weekly Insulin Anti-inflammatory Treatments Clinical Trials Alzheimer's Disease Eculizumab Trials Combination Therapy Semaglutide Research AstraZeneca Bristol Myers Squibb RNA Aptamers Antiviral Therapies

FDA Approves Sotyktu for Active Psoriatic Arthritis as First TYK2 Inhibitor

The decision follows phase 3 POETYK trials showing clinically meaningful 16‑week responses with outcomes observed through one year.

FDA Approves Koselugo for Adults With NF1-Related Plexiform Neurofibromas

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

Six-Month Eculizumab Withdrawal Safe for Most aHUS Patients, Study Finds